Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
about
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
description
clinical trial
@en
klinisch onderzoek
@nl
name
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
@en
type
label
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
@en
prefLabel
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
@en
P1050
P1476
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
@en
P1813
TIM
@en
P3098
NCT02043548
P580
2014-10-01T00:00:00Z
P582
2019-07-30T00:00:00Z